Company registration number 08503371 (England and Wales)
MYHEALTHCARE CLINIC LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
MYHEALTHCARE CLINIC LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 11
MYHEALTHCARE CLINIC LTD
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
4
649,323
706,591
Investments
5
100
100
649,423
706,691
Current assets
Stocks
-
5,224
Debtors - deferred tax
10
7,074,489
5,834,854
Debtors - other
7
1,175,095
997,168
Cash at bank and in hand
68,383
101,188
8,317,967
6,938,434
Creditors: amounts falling due within one year
8
(2,017,204)
(2,544,296)
Net current assets
6,300,763
4,394,138
Total assets less current liabilities
6,950,186
5,100,829
Creditors: amounts falling due after more than one year
9
(29,087,713)
(23,463,860)
Provisions for liabilities
(61,079)
(56,595)
Net liabilities
(22,198,606)
(18,419,626)
Capital and reserves
Called up share capital
11
113
113
Profit and loss reserves
(22,198,719)
(18,419,739)
Total equity
(22,198,606)
(18,419,626)

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 26 March 2026 and are signed on its behalf by:
Mr B Patel
Director
Company registration number 08503371 (England and Wales)
MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

MYHEALTHCARE CLINIC LTD is a private company limited by shares incorporated in England and Wales. The registered office is 18 Fitzhardinge Street, London, W1H 6EQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
20% p.a. reducing balance basis & new site 50% p.a. reducing balance basis
Plant and equipment
25% p.a. reducing balance basis
Fixtures and fittings
25% p.a. reducing balance basis
Computers
33% p.a. reducing balance basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Deferred Tax Recognition

Based on cash flow projections, the company expects to generate future taxable profits. Deferred tax assets have been recognised on the assumption that these profits will allow the company to utilise the tax loss carry forwards and loan interest.

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
2
Judgements and key sources of estimation uncertainty
(Continued)
- 7 -
Intercompany Balances

The intercompany loan between group companies is recognised based on the purpose of the funding and the expected settlement period and is classified as either current or non-current accordingly.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
49
44
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025
596,055
562,551
1,158,606
Additions
27,190
79,056
106,246
Disposals
-
0
(3,547)
(3,547)
At 31 December 2025
623,245
638,060
1,261,305
Depreciation and impairment
At 1 January 2025
125,154
326,861
452,015
Depreciation charged in the year
96,109
65,804
161,913
Eliminated in respect of disposals
-
0
(1,946)
(1,946)
At 31 December 2025
221,263
390,719
611,982
Carrying amount
At 31 December 2025
401,982
247,341
649,323
At 31 December 2024
470,901
235,690
706,591
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
100
100
6
Subsidiaries

Details of the company's subsidiaries at 31 December 2025 are as follows:

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
6
Subsidiaries
(Continued)
- 8 -
Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
MYHEALTHCARE (SERVICES) LIMITED
United Kingdom
General and specialist medical activities.
Ordinary
100.00
The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:
Name of undertaking
Capital and Reserves
Profit/(Loss)
£
£
MYHEALTHCARE (SERVICES) LIMITED
39,061
(1,250)
0
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
269,027
208,158
Corporation tax recoverable
21,507
32,675
Other debtors
884,561
756,335
1,175,095
997,168
2025
2024
Amounts falling due after more than one year:
£
£
Deferred tax asset
7,074,489
5,834,854
Total debtors
8,249,584
6,832,022
8
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
5,000
10,000
Other borrowings
67,205
559,605
Trade creditors
677,587
821,028
Taxation and social security
32,148
105,876
Deferred income
642,552
557,009
Other creditors
26,559
52,674
Accruals
566,153
438,104
2,017,204
2,544,296
MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
9
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Hire purchase and other loans
85,557
121,647
Loans to parent undertakings
27,265,600
21,856,268
Amounts owed to group undertakings
36,556
35,945
Long term deferred directors's remuneration
1,700,000
1,450,000
29,087,713
23,463,860

Included above is loan notes payable to Horizon Global (Healthcare) Ltd, a parent undertaking, totalling £27,265,600 (2024 - £21,822,577), are repayable solely upon the occurrence of an exit event.

10
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
Assets
Assets
2025
2024
2025
2024
Balances:
£
£
£
£
Accelerated capital allowances
61,079
56,595
-
-
Tax losses
-
-
2,637,608
2,324,244
Loan interest
-
-
4,436,881
3,510,610
61,079
56,595
7,074,489
5,834,854
2025
Movements in the year:
£
Asset at 1 January 2025
(5,778,259)
Credit to profit or loss
(1,235,151)
Asset at 31 December 2025
(7,013,410)

The deferred tax asset set out above is expected to reverse more than 12 months and relates to the utilisation of tax losses against future expected profits of the same period. The deferred tax liability set out above is expected to reverse more than 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
11
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of 1p each
10,000
10,000
100
100
Ordinary B shares of 1p each
1,350
1,350
13
13
11,350
11,350
113
113
12
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its loss for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor:
Yashlal Hindocha BA,FCA
Statutory Auditor:
Hindocha & Co Limited
Date of audit report:
26 March 2026
13
Operating lease commitments

Operating lease payments represent rentals payable by the company for certain of its properties. Leases are negotiated for an average term of 10 to 15 years and rentals are fixed with break up close for an average of 5 years.

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows: (Lease agreement includes a break-up clause after 5 years; the figures below encompass the entire term.)

2025
2024
£
£
Operating lease
2,662,402
2,320,212
MYHEALTHCARE CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
14
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

During the year, company was charged loan interest amounting to £3,479,312 ( 2024 - £2,718,511) against loan advanced by the parent undertaking, Horizon Global (Healthcare) Ltd. These loan notes are repayable solely upon the occurrence of an exit event. Loan notes balance at the year end was £27,265,600 (2024 - £21,822,577)

Included in creditors an amount outstanding were as follows:

Myhealthcare (Services) Limited - £36,556 (202 4 - £35,945 ), a wholly owned subsidiary company.

Directors' current account - included in debtors £48,071 (2024 - included in creditors £23,804 )

15
Parent company

The controlling party is Horizon Global (Healthcare) Ltd. The company and its ultimate parent company undertaking are under the control of Mr B Patel and family.

2025-12-31 2025-01-01 false false false 26 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr A Patel Dr S Patel Dr T Sioutis Mr D Gunasekera Mr B Patel 08503371 2025-01-01 2025-12-31 08503371 2025-12-31 08503371 2024-12-31 08503371 core:LandBuildings 2025-12-31 08503371 core:OtherPropertyPlantEquipment 2025-12-31 08503371 core:LandBuildings 2024-12-31 08503371 core:OtherPropertyPlantEquipment 2024-12-31 08503371 core:AfterOneYear 2025-12-31 08503371 core:AfterOneYear 2024-12-31 08503371 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 08503371 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08503371 core:CurrentFinancialInstruments 2025-12-31 08503371 core:CurrentFinancialInstruments 2024-12-31 08503371 core:Non-currentFinancialInstruments 2025-12-31 08503371 core:Non-currentFinancialInstruments 2024-12-31 08503371 core:ShareCapital 2025-12-31 08503371 core:ShareCapital 2024-12-31 08503371 core:RetainedEarningsAccumulatedLosses 2025-12-31 08503371 core:RetainedEarningsAccumulatedLosses 2024-12-31 08503371 core:ShareCapitalOrdinaryShareClass1 2025-12-31 08503371 core:ShareCapitalOrdinaryShareClass1 2024-12-31 08503371 core:ShareCapitalOrdinaryShareClass2 2025-12-31 08503371 core:ShareCapitalOrdinaryShareClass2 2024-12-31 08503371 core:ShareCapitalOrdinaryShares 2025-12-31 08503371 core:ShareCapitalOrdinaryShares 2024-12-31 08503371 bus:Director5 2025-01-01 2025-12-31 08503371 core:LandBuildings core:LongLeaseholdAssets 2025-01-01 2025-12-31 08503371 core:PlantMachinery 2025-01-01 2025-12-31 08503371 core:FurnitureFittings 2025-01-01 2025-12-31 08503371 core:ComputerEquipment 2025-01-01 2025-12-31 08503371 2024-01-01 2024-12-31 08503371 core:LandBuildings 2024-12-31 08503371 core:OtherPropertyPlantEquipment 2024-12-31 08503371 2024-12-31 08503371 core:LandBuildings 2025-01-01 2025-12-31 08503371 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 08503371 core:Subsidiary1 2025-01-01 2025-12-31 08503371 core:Subsidiary1 1 2025-01-01 2025-12-31 08503371 core:Subsidiary1 2025-12-31 08503371 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 08503371 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 08503371 bus:OrdinaryShareClass1 2025-12-31 08503371 bus:OrdinaryShareClass1 2024-12-31 08503371 bus:OrdinaryShareClass2 2025-12-31 08503371 bus:OrdinaryShareClass2 2024-12-31 08503371 bus:AllOrdinaryShares 2025-12-31 08503371 bus:AllOrdinaryShares 2024-12-31 08503371 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 08503371 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 08503371 bus:FRS102 2025-01-01 2025-12-31 08503371 bus:Audited 2025-01-01 2025-12-31 08503371 bus:Director1 2025-01-01 2025-12-31 08503371 bus:Director2 2025-01-01 2025-12-31 08503371 bus:Director3 2025-01-01 2025-12-31 08503371 bus:Director4 2025-01-01 2025-12-31 08503371 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP